CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity
- PMID: 3041033
- PMCID: PMC255886
- DOI: 10.1128/JVI.61.10.3102-3108.1987
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity
Abstract
We have shown in a murine model system for acute, lethal cytomegalovirus (CMV) disease in the immunocompromised natural host that control of virus multiplication in tissues, protection from virus-caused tissue destruction, and survival are mediated by virus-specific CD8+ CD4-T lymphocytes. Protection from a lethal course of disease did not result in a rapid establishment of virus latency, but led to a long-lasting, persistent state of infection. The CD8- CD4+ subset of T lymphocytes was not effective by itself in controlling murine CMV (MCMV) multiplication in tissue or essential for the protective function of the CD8+ CD4- effector cells. The antiviral efficacy of the purified CD8+ CD4- subset was not impaired by preincubation with fibroblasts that presented viral structural antigens, but was significantly reduced after depletion of effector cells specific for the nonstructural immediate-early antigens of MCMV, which are specified by the first among a multitude of viral genes expressed during MCMV replication in permissive cells. Thus, MCMV disease provides the first example of a role for nonstructural herpesvirus immediate-early antigens in protective immunity.
Similar articles
-
Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.Eur J Immunol. 2013 Nov;43(11):2886-95. doi: 10.1002/eji.201343690. Epub 2013 Aug 26. Eur J Immunol. 2013. PMID: 23921569
-
Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes.Immunol Lett. 1987 Dec;16(3-4):185-92. doi: 10.1016/0165-2478(87)90146-5. Immunol Lett. 1987. PMID: 2832318 Review.
-
Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.J Virol. 1994 Jan;68(1):289-97. doi: 10.1128/JVI.68.1.289-297.1994. J Virol. 1994. PMID: 8254740 Free PMC article.
-
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.J Virol. 1990 Nov;64(11):5457-64. doi: 10.1128/JVI.64.11.5457-5464.1990. J Virol. 1990. PMID: 1976821 Free PMC article.
-
Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.Med Microbiol Immunol. 2016 Dec;205(6):549-561. doi: 10.1007/s00430-016-0471-0. Epub 2016 Aug 18. Med Microbiol Immunol. 2016. PMID: 27539576 Review.
Cited by
-
Spatial and temporal distribution of bovine herpesvirus 1 transcripts.J Virol. 1989 Nov;63(11):4882-9. doi: 10.1128/JVI.63.11.4882-4889.1989. J Virol. 1989. PMID: 2552160 Free PMC article.
-
Viral escape mechanisms--escapology taught by viruses.Int J Exp Pathol. 2001 Oct;82(5):269-86. doi: 10.1046/j.1365-2613.2001.00204.x. Int J Exp Pathol. 2001. PMID: 11703537 Free PMC article. Review.
-
A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.Expert Rev Vaccines. 2018 Oct;17(10):889-911. doi: 10.1080/14760584.2018.1526085. Epub 2018 Oct 3. Expert Rev Vaccines. 2018. PMID: 30246580 Free PMC article. Review.
-
Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.J Exp Med. 1998 Aug 3;188(3):577-88. doi: 10.1084/jem.188.3.577. J Exp Med. 1998. PMID: 9687534 Free PMC article.
-
Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients.Cancer Immunol Immunother. 1993 Jul;37(2):131-9. doi: 10.1007/BF01517046. Cancer Immunol Immunother. 1993. PMID: 8391392 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials